Trials / Conditions / Waldenstrom's Disease
Waldenstrom's Disease
5 registered clinical trials studyying Waldenstrom's Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease NCT05911802 | French Innovative Leukemia Organisation | — |
| Recruiting | Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström NCT04893564 | Centre Hospitalier Universitaire, Amiens | N/A |
| Terminated | Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia NCT03679624 | Weill Medical College of Cornell University | Phase 2 |
| Completed | Detection of Recurrent Mutations in Waldenström's Disease NCT03952052 | Centre Henri Becquerel | N/A |
| Completed | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies NCT03329950 | Celldex Therapeutics | Phase 1 |